(Formerly the Biotechnology Council of New Jersey)
1255 Whitehorse Mercerville Road, Building B, Suit
About BioNJWith 200 member companies, BioNJ is singularly focused on the growth and prosperity of New Jersey's biotechnology community.
Founded in 1994 by New Jersey biotechnology industry CEOs, BioNJ serves as the voice of biotechnology companies located in New Jersey, seeks to advance their economic growth and development and works to encourage new and established companies from around the world to locate to New Jersey. BioNJ represents companies engaged in biopharmaceutical, biomedical, bioagricultural and bioremedial endeavors.
The goals and objectives of BioNJ flow from its mission statement:
• To formulate and advocate policy positions to elected State and Federal representatives and other government officials.
• To acquire and coordinate resources and provide services to members regarding issues critical to building successful biotechnology enterprises.
• To enhance awareness and appreciation of New Jersey's biotechnology industry.
83 articles with BioNJ
BioNJ, the life sciences trade association for New Jersey, has released the agenda and speaker roster for its Inaugural Diversity, Equity & Inclusion..Because It Matters Conference, taking place virtually on March 24 and 25, 2021.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
- BioNJ has released its final speaker roster featuring thought leaders from more than 20 leading biopharmaceutical organizations -- for its Eighth Annual C-Suite Summit, taking place virtually October 30 and November 6 .
Leading State Life Sciences Associations Express Concerns with CMS’ Rule on Medicaid Value-Based Agreements
BioNJ, Biocom, the California Life Sciences Association, the HINJ, LSPA, and the Michigan Biosciences Industry Association submitted comments to the CMS on a notice of proposed rulemaking impacting value-based purchasing agreements and other innovative solutions designed to provide patient access to, and purchasing agreements for, cutting edge therapies and cures.
BioNJ's 27th Annual Dinner Meeting & Innovation Celebration Honors New Jersey's Innovators and the Patients Who Inspire Them
New Jersey's life sciences community came out for BioNJ's 27th Annual Dinner Meeting & Innovation Celebration that took place last Thursday, February 6, at the Hilton East Brunswick.
BioNJ's 27th Annual Dinner Meeting & Innovation Celebration to Honor New Jersey's Innovators and the Patients and Advocates Who Inspire Them
Considered the kickoff event of the year for the life sciences industry, BioNJ's 27th Annual Dinner Meeting & Innovation Celebration will take place on Thursday, February 6, 2020 at the Hilton East Brunswick.
BioNJ released "A Framework for Demonstrating the Value of Medical Innovation," a white paper authored by Shailja Dixit, M.D., M.S., M.P.H., President & Founder, ApexBio, and Robert Goldberg, Ph.D., Vice President & Founder, Center for Medicine in the Public Interest, that outlines a structure for innovator companies to assess and demonstrate "Differential Value" for a medical innovation prior to bringing it to market.
BioNJ's Ninth Annual BioPartnering Conference, scheduled for Wednesday, May 8, 2019 at The Palace at Somerset Park, Somerset, NJ, will bring together more than 400 life sciences professionals from the Northeast to Mid-Atlantic states for a day of networking, 1:1 partnering meetings, company presentations, posters, exhibits and plenary sessions.
7/16/2018With the Independence Day holiday in the rearview mirror, numerous biopharma companies continued to adjust their leadership ranks and strengthen the members of various boards representing and overseeing the companies.
New Jersey is being touted as a national leader at the BIO International Convention, taking place this week in Boston.
Registration Is Now Open For BioNJ’s Fifth Annual CEO Summit: Industry's New World Order And Implications For Innovation — Unprecedented Challenges/Unparalleled Opportunities
BioNJ's 4th Annual CEO Summit: A Funny Thing Happened On The Way To The Market... With Insights From McKinsey and Company
BioNJ Report: Clinical Trials Activity In New Jersey Delivers 3,750 Jobs And $779M In Economic Output
BioNJ Release: New Jersey Touted As National Leader In "Value Of Bioscience Innovation In Growing Jobs And Improving Quality Of Life 2016" Report